Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
11
3
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Continuous Vs Intermittent Non Invasive Blood Pressure Monitoring in Preventing Post Operative Organ Failure
Role: collaborator
Neurological Events and Unforeseen Risks After Locoregional-anesthesia
Role: lead
Helmet NIV vs. CPAP vs. High-flow Nasal Oxygen in Hypoxemic Respiratory Failure
Role: collaborator
HIgh Versus STAndard Blood Pressure Target in Hypertensive High-risk Patients Undergoing Major Abdominal Surgery
Role: collaborator
Chronic Postsurgical Pain: Multivariate Prediction Model
Role: lead
Complexity and Frailty in Cardiothoracic and Vascular Anesthesia (CAfCA). Prospective Multicentric Observational Study
Role: collaborator
Registro Italiano Dei Pazienti Affetti da Dolore Cronico
Role: lead
Helmet Noninvasive Ventilation vs. High-flow Nasal Cannula in Moderate-to-severe Acute Hypoxemic Respiratory Failure
Role: collaborator
Early Neurological Assessment With Pupillometry in Cardiac Arrest During Resuscitation
Role: lead
High-flow Nasal Cannula vs. Helmet PSV vs. Helmet CPAP During Respiratory Failure
Role: collaborator
Intensiva 2.0: Improve the Communication Towards Families of Critically Ill Patients
Role: collaborator
All 11 trials loaded